CMPX
Price
$2.17
Change
+$0.03 (+1.40%)
Updated
Jun 4 closing price
Capitalization
300.07M
55 days until earnings call
CPRX
Price
$25.29
Change
+$0.38 (+1.53%)
Updated
Jun 4 closing price
Capitalization
3.08B
62 days until earnings call
Interact to see
Advertisement

CMPX vs CPRX

Header iconCMPX vs CPRX Comparison
Open Charts CMPX vs CPRXBanner chart's image
Compass Therapeutics
Price$2.17
Change+$0.03 (+1.40%)
Volume$1.44M
Capitalization300.07M
Catalyst Pharmaceuticals
Price$25.29
Change+$0.38 (+1.53%)
Volume$1.12M
Capitalization3.08B
CMPX vs CPRX Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. CPRX commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Buy and CPRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (CMPX: $2.17 vs. CPRX: $25.29)
Brand notoriety: CMPX and CPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 89% vs. CPRX: 100%
Market capitalization -- CMPX: $300.07M vs. CPRX: $3.08B
CMPX [@Biotechnology] is valued at $300.07M. CPRX’s [@Biotechnology] market capitalization is $3.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileCPRX’s FA Score has 2 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • CPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, CPRX is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 5 TA indicator(s) are bullish while CPRX’s TA Score has 5 bullish TA indicator(s).

  • CMPX’s TA Score: 5 bullish, 2 bearish.
  • CPRX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CMPX is a better buy in the short-term than CPRX.

Price Growth

CMPX (@Biotechnology) experienced а +2.84% price change this week, while CPRX (@Biotechnology) price change was +1.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

CMPX is expected to report earnings on Jul 30, 2025.

CPRX is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($3.09B) has a higher market cap than CMPX($300M). CMPX YTD gains are higher at: 49.655 vs. CPRX (21.179). CPRX has higher annual earnings (EBITDA): 269M vs. CMPX (-60.17M). CPRX has more cash in the bank: 581M vs. CMPX (113M). CPRX has less debt than CMPX: CPRX (3.09M) vs CMPX (6.38M). CPRX has higher revenues than CMPX: CPRX (535M) vs CMPX (850K).
CMPXCPRXCMPX / CPRX
Capitalization300M3.09B10%
EBITDA-60.17M269M-22%
Gain YTD49.65521.179234%
P/E RatioN/A15.87-
Revenue850K535M0%
Total Cash113M581M19%
Total Debt6.38M3.09M206%
FUNDAMENTALS RATINGS
CPRX: Fundamental Ratings
CPRX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
33
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
40

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXCPRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 15 days ago
69%
BollingerBands
ODDS (%)
N/A
Bearish Trend 7 days ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEGFX60.320.41
+0.68%
American Funds Europacific Growth F1
FDEGX72.15N/A
N/A
Fidelity Growth Strategies
DPREX12.66N/A
N/A
Macquarie Global Listed Real Assets A
GSGSX47.03N/A
N/A
Goldman Sachs Equity Income Svc
IOGPX7.27N/A
N/A
Voya Global Insights Portfolio S2

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+1.40%
VCYT - CMPX
37%
Loosely correlated
+2.98%
SANA - CMPX
35%
Loosely correlated
-0.85%
FHTX - CMPX
35%
Loosely correlated
-3.67%
VIR - CMPX
35%
Loosely correlated
+0.96%
CPRX - CMPX
34%
Loosely correlated
+1.53%
More

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with VIR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+1.53%
VIR - CPRX
45%
Loosely correlated
+0.96%
CRNX - CPRX
44%
Loosely correlated
+0.78%
SANA - CPRX
44%
Loosely correlated
-0.85%
LGND - CPRX
42%
Loosely correlated
+1.42%
FOLD - CPRX
41%
Loosely correlated
-2.56%
More